UNSPECIFIED ADULT SOLID TUMOR, PROTOCOL SPECIFIC
Clinical trials for UNSPECIFIED ADULT SOLID TUMOR, PROTOCOL SPECIFIC explained in plain language.
Never miss a new study
Get alerted when new UNSPECIFIED ADULT SOLID TUMOR, PROTOCOL SPECIFIC trials appear
Sign up with your email to follow new studies for UNSPECIFIED ADULT SOLID TUMOR, PROTOCOL SPECIFIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug COH29 targets tumor growth enzyme in advanced cancers
Disease control OngoingThis early-phase trial tests an experimental drug called COH29 in people with advanced solid tumors that have stopped responding to standard treatments or have no standard therapy available. COH29 works by blocking an enzyme that cancer cells need to grow and multiply. The main g…
Matched conditions: UNSPECIFIED ADULT SOLID TUMOR, PROTOCOL SPECIFIC
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can a new tracer light up cancer growth?
Diagnosis OngoingThis trial is testing a new imaging tracer called FLT, which is used with a PET scan to measure how fast tumors are growing. The study includes people with various cancers or those awaiting a biopsy for a suspicious mass. The goal is to see if FLT PET imaging can help find and di…
Matched conditions: UNSPECIFIED ADULT SOLID TUMOR, PROTOCOL SPECIFIC
Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC
-
New PET scan aims to spot hidden cancers with precision
Diagnosis OngoingThis study tests a special PET scan that uses a radioactive antibody (64Cu-M5A) to find cancers that produce a protein called CEA. The goal is to see if this scan can detect tumors that standard methods might miss. About 20 adults with CEA-positive cancers (such as breast, colon,…
Matched conditions: UNSPECIFIED ADULT SOLID TUMOR, PROTOCOL SPECIFIC
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC
-
New tool aims to predict chemo risks for seniors
Knowledge-focused OngoingThis study tests whether a geriatric assessment tool—looking at thinking, memory, daily activities, and emotional well-being—can predict serious side effects from chemotherapy in older adults with cancer. Over 1,000 patients completed questionnaires and cognitive tests before and…
Matched conditions: UNSPECIFIED ADULT SOLID TUMOR, PROTOCOL SPECIFIC
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC